InMed Pharmaceuticals (INM) FCF Margin (QoQ) (2022 - 2025)
InMed Pharmaceuticals (INM) FCF Margin (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | InMed Pharmaceuticals | 6.56 Mn | 1.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,620.00 |
| Sep 30, 2025 | -721.00 |
| Jun 30, 2025 | -477.00 |
| Mar 31, 2025 | 9,353.00 |
| Dec 31, 2024 | -8,062.00 |
| Sep 30, 2024 | -6,424.00 |
| Jun 30, 2024 | 8,596.00 |
| Mar 31, 2024 | -1,730.00 |
| Dec 31, 2023 | 9,186.00 |
| Sep 30, 2023 | -20,510.00 |
| Jun 30, 2023 | 12,460.00 |
| Mar 31, 2023 | 41,729.00 |
| Dec 31, 2022 | 12,389.00 |
| Sep 30, 2022 | 9,805.00 |
| Jun 30, 2022 | 9,192.00 |
| Mar 31, 2022 | 34,510.00 |